USPTO Extends AFCP 2.0 and QPIDS Pilot Programs
The USPTO has announced that both the After Final Consideration Pilot (AFCP) 2.0 and the Quick Path Information Disclosure Statement…
The USPTO has announced that both the After Final Consideration Pilot (AFCP) 2.0 and the Quick Path Information Disclosure Statement…
Filing for a foreign license can appear a daunting task. Below is a brief summary when it comes to requesting…
In June 2017, we wrote about the United States Patent and Trademark Office (USPTO) extending the Cancer Immunotherapy Pilot Program…
Allergan and the Saint Regis Mohawk Tribe have announced that the Saint Regis Mohawk Tribe [“the Tribe”] is now the…
In its recent decision in In re Stepan Co., The Court of Appeals for the Federal Circuit vacated an obviousness…